Statine e sindromi coronariche acute : evidenze per la scelta di un trattamento appropriato Dott Antonio Giomi Emodinamica AUSL 3 Pistoia Villa Cappugi.
CURRENT OASIS 7: A 2X2 Factorial Randomized Trial of Optimal Clopidogrel and Aspirin Dosing in Patients with ACS Undergoing an Early Invasive Strategy.
Diabetes and Cardiovascular Risk La lezione dai grandi studi di intervento.
LANDMARK TRIALS IN STABLE CAD
Efficacy of statins in primary and secondary prevention of CV events - well established Meta-analyses of RCTs : - demonstrated dramatic reductions in.
Statin therapy: striking a balance between prevention and disease control for the heart Michele Emdin Giuseppe Vergaro, Gianluca Mirizzi, Luigi Emilio.
OASIS-7
Data Monitoring for Safety apparent harm with a new treatment ILLUMINATE trial
The overwhelming case for LDL-C lowering Prof Kausik Ray, BSc (hons), MBChB, FRCP, MD, MPhil (Cantab), FACC, FESC Professor of Cardiovascular Disease Prevention.
Introduction Bernard Zinman CM, MD, FRCP, FACP Director, Leadership Sinai Centre for Diabetes Professor of Medicine, University of Toronto 1.
Pr. SELIM JAMBART Chef du service d’endocrinologie et des maladies métaboliques
Supported by a grant from Novartis Pharmaceuticals
